Physician profile
Hammad Khan
NPI 1992904395
$9,311.19
in general payments reported to CMS, 2019-2025
36 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $351 · 2021: $366 · 2022: $575 · 2023: $429 · 2024: $6,719 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,026 · Food and Beverage: $2,406 · Entertainment: $15.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,026.14 |
| Food and Beverage | $2,406.35 |
| Entertainment | $15.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,936.42 | 2020-2024 | Versacross Access Solution |
| Abbott Laboratories | $2,019.26 | 2024 | Perclose Proglide, Mitraclip |
| Bard Peripheral Vascular, INC. | $1,294.95 | 2024 | Venclose Maven Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $662.92 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $511.82 | 2019-2025 | |
| Amgen INC. | $250.68 | 2019-2024 | Repatha |
| Pfizer INC. | $230.99 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $192.00 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $175.25 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $153.08 | 2019-2024 | Xarelto |
| Abiomed | $84.17 | 2019-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $77.11 | 2019-2025 | Eliquis, Camzyos |
| Lexicon Pharmaceuticals, INC. | $74.83 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals Lp | $67.47 | 2020-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.99 | 2022-2024 | Jardiance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $38.05 | 2022-2025 | |
| Astellas Pharma US INC | $37.76 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $37.41 | 2021-2022 | |
| Braemar Manufacturing, LLC | $37.25 | 2019 | |
| Preventice Services, LLC | $37.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $34.56 | 2022-2024 | Assure Wcd |
| Heartflow, INC. | $31.35 | 2020 | |
| Edwards Lifesciences Corporation | $31.28 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $30.74 | 2023 | Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $27.84 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $24.90 | 2021 | |
| Scpharmaceuticals INC. | $24.72 | 2024 | |
| Cook Medical LLC | $24.20 | 2019 | |
| Portola Pharmaceuticals, LLC | $23.52 | 2019 | |
| Celgene Corporation | $20.65 | 2024 | Camzyos |
| Opsens INC. | $15.20 | 2023 | Optowire |
| Medtronic, INC. | $14.83 | 2025 | Mycarelink |
| Biotronik INC. | $14.07 | 2019 | |
| Esperion Therapeutics, INC. | $13.83 | 2021 | |
| Cardinal Health 200 LLC | $13.09 | 2020 | |
| Zoll Circulation INC | $8.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.